Company
Headquarters: Linhai, China
Employees: 6,655
CN¥22.85 Billion
CNY as of Jan. 1, 2025
US$3.13 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also engages in packaging components business, such as high-density polyethylene bottles and polypropylene caps. In addition, the company provides contract manufacturing and other services. Further, it is involved in import and export trade services. Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥9.35 B |
| EBITDA | CN¥1.96 B |
| Gross Profit TTM | CN¥5.81 B |
| Profit Margin | 12.20% |
| Operating Margin | 24.62% |
| Quarterly Revenue Growth | 10.80% |
Zhejiang Huahai Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SSE: 600521 wb_incandescent